Shenzhen's medtech investment and policy sets the stage for innovation and growth

For 2010, industrial sales from the biological sector in Shenzhen alone exceeded 50 billion Chinese Yuan (CNY), with a growth rate of 30%. With medical equipment accounting for approximately 50% of Guangdong's exports and 13% for the country overall, Shenzhen is a highly influential hub for high-te...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

EU Commission proposes €10 billion in funding for 10 public-private partnerships to bolster the region's innovation ecosystem

News Commentary | March 04, 2021

The €10 billion will be split across 10 major projects, including healthcare, circular economy, hydrogen, and connectivity technologies. At its core, this is a significant step by the EU to strengthen its leading position in certain areas while also keeping pace with rising competition from around ... Not part of subscription

Dubai's economic agency launches new digital health-focused incubator and accelerator

News Commentary | April 30, 2021

The new incubator and accelerator, called Ztartup, aims to further the role of Dubai as a knowledge center and innovation hub in the region. The Middle East, most notably Saudi Arabia, the United Arab Emirates, and Qatar, has overseen major investments from the government in building R&D ... Not part of subscription

EBRD and GCF launch $1 billion program to support industrial decarbonization across seven countries

News Commentary | June 14, 2021

The European Bank for Reconstruction and Development (EBRD), in collaboration with the Green Climate Fund (GCF), is launching the "High Impact Programme for the Corporate Sector," aiming to promote the adoption of low‑carbon technologies in the industrial sector. The expectation is to reduce ... Not part of subscription